trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Cancer cells can hide from the immune system to continue growing and spreading.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
10 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that cancer cells can hide from the immune system to continue growing and spreading?

Yes. Extensive oncological research demonstrates that cancer cells employ diverse strategies—such as altering antigen presentation, modifying the tumor microenvironment, and co-opting metabolic and signaling pathways—to evade the immune system and drive tumor progression.

Verdict: SUPPORTED · 10 sources for, 0 against · Last checked

The analysis

The claim is a specific, well-established biological reality in oncology. All retrieved papers thoroughly support the premise that cancer cells utilize various mechanisms to hide from or suppress the immune system, enabling continued growth and spreading.

Evidence for · 10
2025
Discusses how tumors evade detection and eradication by downregulating antigens and modulating immune pathways.
Get citation
Ruan, L. & Wang, L. (2025). Adoptive cell therapy against tumor immune evasion: mechanisms, innovations, and future directions. doi.org. https://doi.org/10.3389/fonc.2025.1530541

See more details
More for · 9
2023
Explains how metabolic changes within the tumor microenvironment help tumors hinder the immune response.
Get citation
L, C., Y, W., Q, H., Y, L., X, Q., Z, T., H, H., N, L., S, Z., & L, Y. (2023). Unveiling tumor immune evasion mechanisms: abnormal expression of transporters on immune cells in the tumor microenvironment.. doi.org. https://doi.org/10.3389/fimmu.2023.1225948

2022
Details how tumor cells evolve mechanisms to avoid immune cell detection and killing, resulting in tumor progression.
Get citation
Q, W. & K, T. (2022). Immunoregulatory signal networks and tumor immune evasion mechanisms: insights into therapeutic targets and agents in clinical development.. doi.org. https://doi.org/10.1042/bcj20210233

2025
Highlights mitochondrial transfer as a key mechanism supporting tumor progression and immune evasion.
Get citation
R, L., W, S., Z, W., H, W., C, L., L, Y., & R, G. (2025). Unveiling mitochondrial transfer in tumor immune evasion: mechanisms, challenges, and clinical implications.. doi.org. https://doi.org/10.3389/fimmu.2025.1625814

2026
Explores how RNA modifications regulate tumor immune visibility and help cancer cells escape immune destruction.
Get citation
Y, M., W, D., X, J., & Y, Z. (2026). RNA epitranscriptomic regulation of tumor immune evasion: mechanisms, context-dependent roles, and therapeutic implications.. doi.org. https://doi.org/10.3389/fimmu.2026.1857099

2026
Examines how mitophagy and metabolic-immune hubs drive immune evasion in skin cancers to foster tumor growth.
Get citation
J, L. & G, L. (2026). Mitophagy-driven immune evasion in skin cancer: multidimensional regulatory networks and context-dependent therapeutic strategies-a narrative review.. doi.org. https://doi.org/10.3389/fimmu.2026.1949371

2026
Identifies epigenetic dysregulation and immune escape as key drivers of tumor evasion and treatment resistance.
Get citation
R, P. & EF, L. (2026). Targeting the Epigenetic-Immune Axes in Hematologic Malignancies.. doi.org. https://doi.org/10.3390/cancers18182985

2026
Demonstrates how specific mRNA modifications promote immune evasion and inhibit CD8+ T-cell activity in colorectal cancer.
Get citation
W, C. (2026). IGF2BP3-Mediated m6A Modification of OLR1 mRNA Promotes Immune Evasion in CRC via the PI3K/AKT/mTOR Pathway.. doi.org. https://doi.org/10.1097/cji.0000000000000613

2025
Reviews how suppressive cells and soluble mediators in the tumor microenvironment facilitate immune evasion and survival.
Get citation
Hernández, J. L. G. & Smith, J. (2025). Tumor Microenvironment and Immune Evasion Mechanisms. doi.org. https://doi.org/10.70996/cip.00005

2025
Summarizes how tumors develop various evasion strategies, such as losing antigen presentation and expressing checkpoint ligands, to avoid destruction and continue growing.
Get citation
LI, M. (2025). Tumor Immune Evasion Mechanisms and Immunotherapy Strategies. doi.org. https://doi.org/10.54254/2753-8818/2025.au27725

What does the evidence say?

The claim is a specific, well-established biological reality in oncology. All retrieved papers thoroughly support the premise that cancer cells utilize various mechanisms to hide from or suppress the immune system, enabling continued growth and spreading.

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work